BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9336145)

  • 1. Time-dose considerations in the treatment of anal cancer.
    Constantinou EC; Daly W; Fung CY; Willett CG; Kaufman DS; DeLaney TF
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):651-7. PubMed ID: 9336145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.
    Ajani JA; Winter KA; Gunderson LL; Pedersen J; Benson AB; Thomas CR; Mayer RJ; Haddock MG; Rich TA; Willett C
    JAMA; 2008 Apr; 299(16):1914-21. PubMed ID: 18430910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy for epidermoid carcinoma of the anus: thirty years' experience.
    Myerson RJ; Outlaw ED; Chang A; Birnbaum EH; Fleshman JW; Grigsby PW; Kodner IJ; Malayapa RS; Mutch MG; Parikh P; Picus J; Tan BR
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):428-35. PubMed ID: 19251377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-positive patients receiving highly active antiretroviral therapy.
    Fraunholz I; Weiss C; Eberlein K; Haberl A; Rödel C
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1425-32. PubMed ID: 19744801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.
    Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08.
    John M; Pajak T; Flam M; Hoffman J; Markoe A; Wolkov H; Paris K
    Cancer J Sci Am; 1996; 2(4):205-11. PubMed ID: 9166533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
    Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
    Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher radiation dose with a shorter treatment duration improves outcome for locally advanced carcinoma of anal canal.
    Huang K; Haas-Kogan D; Weinberg V; Krieg R
    World J Gastroenterol; 2007 Feb; 13(6):895-900. PubMed ID: 17352019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoradiation for adenocarcinoma of the anus.
    Papagikos M; Crane CH; Skibber J; Janjan NA; Feig B; Rodriguez-Bigas MA; Hung A; Wolff RA; Delclos M; Lin E; Cleary K
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):669-78. PubMed ID: 12573754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Squamous cell carcinoma of the anal canal.
    Mitchell SE; Mendenhall WM; Zlotecki RA; Carroll RR
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1007-13. PubMed ID: 11240241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities.
    Edelman S; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):206-11. PubMed ID: 16904522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with split-course external beam irradiation +/- chemotherapy and integrated Ir-192 high-dose-rate brachytherapy in the treatment of primary carcinomas of the anal canal.
    Kapp KS; Geyer E; Gebhart FH; Oechs AC; Berger A; Hebenstreit J; Stoeger H
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):997-1005. PubMed ID: 11240240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy.
    Kachnic LA; Tsai HK; Coen JJ; Blaszkowsky LS; Hartshorn K; Kwak EL; Willins JD; Ryan DP; Hong TS
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):153-8. PubMed ID: 21095071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy.
    Graf R; Wust P; Hildebrandt B; Gögler H; Ullrich R; Herrmann R; Riess H; Felix R
    Oncology; 2003; 65(1):14-22. PubMed ID: 12837978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.
    Seo Y; Kinsella MT; Reynolds HL; Chipman G; Remick SC; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):143-9. PubMed ID: 19203845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal.
    Peddada AV; Smith DE; Rao AR; Frost DB; Kagan AR
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1101-5. PubMed ID: 9169819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal.
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Houry S; Gallot D; Parc R; Huang R; Qu SH; Huart J; Pène F; Schlienger M
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1259-73. PubMed ID: 12873670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients.
    Valentini V; Coco C; Picciocchi A; Morganti AG; Trodella L; Ciabattoni A; Cellini F; Barbaro B; Cogliandolo S; Nuzzo G; Doglietto GB; Ambesi-Impiombato F; Cosimelli M
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):664-74. PubMed ID: 12062610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of p53 protein and outcome of patients treated with chemoradiation for carcinoma of the anal canal: a report of randomized trial RTOG 87-04. Radiation Therapy Oncology Group.
    Bonin SR; Pajak TF; Russell AH; Coia LR; Paris KJ; Flam MS; Sauter ER
    Cancer; 1999 Mar; 85(6):1226-33. PubMed ID: 10189126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.